News
News Center
2024-02-20
Encourage biotech companies and medical institutions in the New Area to leverage their technical capabilities by applying for cutting-edge medical technology research projects focused on clinical stem cell studies. Additionally, support medical institutions, research organizations, and specialized service providers in the New Area to host international biopharmaceutical conferences.
+
2024-01-24
The "father of bone marrow mesenchymal stem cells" passes away
The pivotal moment in his career came when he successfully isolated human mesenchymal stem cells (MSCs) from adult bone marrow, laying the conceptual and technical groundwork for subsequent global research.
+
2024-01-10
Support the development and application of comprehensive management standards for new drugs, medical devices, and cutting-edge technologies. Allow cell and gene therapy companies to conduct clinical applications of restricted cell transplantation techniques at medical institutions, provided they have registered with the health authorities. Additionally, permit eligible Hong Kong and Macao-based enterprises to leverage domestic human genetic resources for medical research activities—excluding human stem cell studies and gene-based diagnostics or therapies.
+
2023-12-11
Fitness superstar Chris: Undergoing stem cell therapy as kidney issues raise concerns.
Recently, foreign media reported that international bodybuilding superstar Chris is undergoing stem-cell therapy, aimed at preventing potential future health issues.
+
2023-12-11
On December 3, 2023, Jiuzhitang Maker’s preclinical pharmacodynamic study titled "Intravenous transplantation of bone marrow-derived mesenchymal stem cells improved behavioral deficits and altered fecal microbiota composition of BTBR mice," which explores the use of human bone marrow mesenchymal stem cells (hBMMSC) to treat autism, was officially accepted and published in the internationally renowned academic journal *Life Sciences*.
+
2023-12-11
Jiuzhitang Maker named to Huayi List's "Top 10 Most Promising Stem Cell Companies" list
On December 7-8, 2023, the highly anticipated "Huayi List · 2023 Cell and Gene Therapy Industry Visionary Ranking," jointly launched by YiYun Technology, Pinhe Medical, and BioValley, was officially unveiled. Jiuzhitang Maker was named among the "Top 10 Most Promising Stem Cell Companies" on the Huayi List.
+
2023-11-23
Jiuzhitang Maker's participation in establishing the Hunan Provincial Key Laboratory is a strong recognition of the company's deep expertise and groundbreaking research achievements in stem-cell-based pharmaceutical quality. It also highlights the critical R&D direction for stem-cell products in the pharmaceutical field. Moving forward, Jiuzhitang Maker will fully leverage its cutting-edge stem-cell research capabilities to drive innovation and accelerate clinical translation of stem-cell technologies, continuously fueling the high-quality development of the Hunan Provincial Key Laboratory.
+
2023-11-21
“Standards provide a valuable reference for both research and application, serving as a fundamental guarantee for industry development,” said Ji Weizhi, an academician of the Chinese Academy of Sciences and director of the Primate Translational Medicine Research Institute at Kunming University of Science and Technology. He added that currently, developing standards in the stem cell field still faces significant challenges. However, as research into stem cell theories and technologies continues to advance, he believes more innovative standards will emerge—while existing ones will be refined further—to better propel progress in this cutting-edge area.
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy